Skip to main content
. 2016 Sep 16;95(37):e4608. doi: 10.1097/MD.0000000000004608

Figure 2.

Figure 2

Expression levels of GAS5 in NSCLC patients and healthy controls. A, lncRNA-GAS5 was significantly down-regulated in NSCLC patients (n = 90) compared with healthy controls (n = 33). B, Plasma GAS5 expression levels in NSCLC with various tumor grades. C, Wilcoxon t test analysis of GAS5 expression levels between preoperative and postoperative samples obtained from NSCLC patients. GAS5 = growth arrest-specific transcript 5, NSCLC = nonsmall cell lung cancer.